Opportunity
DIBBS #SPE2DP-26-T-3112
DLA Solicitation for Guaifenesin Extended-Release Tablets (NSN 6505-01-724-9533)
Posted
April 28, 2026
Respond By
May 04, 2026
Identifier
SPE2DP-26-T-3112
NAICS
424210
The Defense Logistics Agency (DLA) is soliciting bids for the supply of Guaifenesin Extended-Release Tablets for military use. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - Buyer: Alec Deichman - Products Requested: - Guaifenesin Extended-Release Tablets, 1200mg, 14 tablets per box - National Stock Number (NSN): 6505-01-724-9533 - Quantity: 2 boxes - Part numbers: NDC46122-0683-74 (AmerisourceBergen Drug Corp), NDC63824-0023-35 (RB Health US LLC) - OEMs and Vendors: - AmerisourceBergen Drug Corp - RB Health US LLC - Notable Requirements: - Delivery required within 20 days to Fort Bragg, NC - Must comply with domestic sourcing laws - Hazardous material labeling required - Cybersecurity compliance per NIST SP 800-171 - Product must be immediate and extended release bi-layer tablets, not for children under 12, and stored at 20-25°C (68-77°F) - Delivery Location: - 3D SFG SSA AWCF SSF, 5234 Eagle Talon Dr Bldg X3063, Fort Bragg, NC 28310
Description
GUAIFENESIN EXTENDE (QTY: 2, NSN: 6505-01-724-9533, Purchase Request: 7016505411) Approved Sources: - CAGE: 1XUY5, Part No: NDC46122-0683-74, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 860J1, Part No: NDC63824-0023-35, Company: RB HEALTH US LLC